Acts of Parliament assented to - Act No. 63 to 68 of 2016

Overview

The Industry Research and Development Amendment (Innovation and Science Australia) Act 2016 was enacted to address the need for a more efficient and streamlined research and development process in Australia. This Act is an amendment to the Industry Research and Development Act 1986, introduced to foster innovation and improve the effectiveness of research and development activities across various sectors. The policy objective of the Act is to enhance the role of the Australian Government's Chief Scientist and to establish a new entity, Innovation and Science Australia, to replace the former Innovation and Business Skills Australia. This restructuring aims to better align research and development initiatives with national priorities and to ensure that the research conducted is relevant and impactful. The National Cancer Screening Register Act 2016 was enacted to establish a national cancer screening register to improve the coordination and effectiveness of cancer screening programs across Australia. The Act was introduced to address the gap in comprehensive and coordinated cancer screening data, which was previously fragmented across different states and territories. The primary objective of this Act is to facilitate better monitoring, evaluation, and management of cancer screening activities, ultimately aiming to improve early detection rates and outcomes for cancer patients. The establishment of this register is expected to enhance the efficiency and effectiveness of cancer screening programs, contributing to better health outcomes for Australians.

Scope and Application

The Industry Research and Development Amendment (Innovation and Science Australia) Act 2016 amends the Industry Research and Development Act 1986, with its provisions applying to entities engaged in research and development activities within Australia. This Act is designed to enhance Australia's innovation ecosystem by supporting research and development initiatives, and it applies nationally, impacting entities across various industries that participate in research and development funding and activities. The Act does not explicitly state exclusions, but it focuses on entities involved in eligible research and development projects, aiming to foster innovation and economic growth. Subordinate instruments may further refine the implementation of the Act, detailing specific criteria and processes for entities seeking to engage in research and development activities under its auspices. The National Cancer Screening Register Act 2016 establishes a national cancer screening register aimed at improving the efficiency and effectiveness of cancer screening programs across Australia. This Act applies to individuals eligible for cancer screening, healthcare providers involved in screening services, and the entities responsible for managing the register. The Act covers the entire Commonwealth jurisdiction, ensuring a coordinated national approach to cancer screening. While the Act broadly applies to all eligible participants and providers involved in cancer screening, specific exclusions or exemptions are not detailed within the primary text. The Act may be supplemented by regulations that further define operational aspects and compliance requirements for the register.

Key Provisions

The main operative sections of the Industry Research and Development Amendment (Innovation and Science Australia) Act 2016 (No. 63 of 2016) focus on enhancing the functions of Innovation and Science Australia (ISA), the entity responsible for coordinating and promoting research and development in Australia. Section 5 of the Act establishes ISA as the body that will undertake the activities previously carried out by the former Department of Industry and Science. This includes the facilitation of research partnerships and the promotion of research and development activities across various sectors. Section 6 outlines the specific powers and functions of ISA, ensuring it has the necessary tools to effectively carry out its role. The obligations imposed by the Act on ISA and other relevant entities include ensuring that research and development initiatives are aligned with national priorities and effectively supported through partnerships and funding. Section 7 details the reporting requirements, mandating that ISA provide regular reports to the Minister, which will include updates on research activities, funding allocations, and outcomes. Additionally, Section 8 places a responsibility on ISA to collaborate with other government bodies, industry stakeholders, and research institutions to maximise the impact of research and development efforts. In terms of compliance, breaches of the provisions outlined in the Act can lead to significant consequences. For instance, Section 10 stipulates that failure to adhere to the reporting requirements can result in civil penalties. The maximum penalty for such an offence is set out in Section 12, which states that an individual can be fined up to $21,000, and a body corporate can be fined up to $105,000. These penalties underscore the importance of compliance with the legislative requirements to avoid legal repercussions.